MacroGenics reported $802K in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
AbbVie USD 700M 90M Mar/2025
Amgen USD 694M 29M Jun/2025
AstraZeneca 303M 126M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Daiichi Sankyo 1.42B 5.66B Jun/2025
Eli Lilly USD 249M 5.3M Jun/2025
Genmab DKK 9M 4M Jun/2025
Geron USD 8.52M 233K Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
J&J USD 128M 9M Mar/2025
MacroGenics USD 802K 826K Jun/2025
Merck USD 305M 8M Jun/2025
Pfizer USD 654M 0 Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Xencor 8.24M 422K Jun/2025